Welcome to 340B Employed
340B Employed is the premier provider of career resources for professionals who lead, manage, and work in 340B roles within hospitals, corporations, pharmacies, nonprofits, or other healthcare entities. Our online career center brings together the 340B community and will allow both job seekers and employers to find the perfect match.
Did you know, 340B Employed also provides valuable tools and services including resume writing, career coaching, and reference checking.
Explore 340B Employed and start your search today!
Follow us on X
Rebates in place of 340B discounts would undermine access to care at critical hospitals - forcing cuts, staffing delays, and even closures. When safety-net providers struggle, patients and communities feel it first. #340B #HealthEquity #Protect340B
Richard nearly slipped into a coma from severe iron-deficiency anemia. Uninsured and out of work, he received lifesaving transfusions. #Becauseof340B, he saved $30,000 on medications during recovery. Hear his story. #340B
Hospitals shouldn’t be forced to pay full price upfront and wait for rebates that might never come. Drugmakers' 340B rebate schemes threaten hospital finances and patient care. Read the full report: https://www.340bhealth.org/files/340B-RebateScheme-Final.pdf
340B Health has consistently raised concerns about moving 340B from upfront discounts to a rebate model — it could create cash-flow challenges and administrative burdens for hospitals already operating on thin margins.
The US Department of Health and Human Services for the second time is seeking information on how it should implement the potential use of rebates in a drug discount program after its first proposal was shot down in federal court. https://news.bloomberglaw.com/health-law-and-business/hhs-seeks-details-as-it-weighs-second-attempt-at-drug-rebates?taid=698fde2dcaae220001a8feaf&utm_campaign=trueanthem&utm_medium=social&utm_source=twitter
#ICYMI: New episode of the 340B Insight podcast: Our experts answer listener questions on the CMS drug acquisition cost survey, state 340B legislation in 2026, new Medicare drug price caps, and more.
Listen now: